Although the role of some members of the IL-1 cytokine family in liver disease has been extensively studied (IL-1α, IL-1β, IL-33), leading to strong arguments favoring these molecules as potential therapeutic targets, the role of the other members (IL-36, IL-37, IL-38) remains to be elucidated. The gene discussed is IL1A; the disease is liver disorder.